The inhibition of acetylcholinesterase (AChE) is also a well-established mechanism in AD treatment, as it increases the levels of acetylcholine in the brain, a neurotransmitter that is typically reduced in patients with AD [21]. Here, ACHE is linked to Alzheimer disease.